Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

BMJ 2002; 325 doi: http://dx.doi.org/10.1136/bmj.325.7374.1202 (Published 23 November 2002)
Cite this as: BMJ 2002;325:1202

Related articles

Research: The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis

Research: Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study

Analysis and Comment: Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence

Editorial: The polypill and cardiovascular disease

Letter: Folate and risk of cardiovascular disease

This Week In the BMJ: High homocysteine causes cardiovascular disease

See more

News: Americans should lower salt intake but not too much, review says

News: Autopsies using MRIs in babies and infants could help improve uptake rates

News: Challenge to research on heart disease patterns in India sparks controversy

Research News: No cardiovascular benefit from fish oil for high risk adults

Research News: Uninterrupted anticoagulation during pacemaker or defibrillator surgery

This article has been cited by other articles:

THIS WEEK'S POLL